We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVNI:NASDAQNvni Group Limited Analysis

Data as of 2026-06-12 - not real-time

$0.87

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Nvni Group Limited trades at $0.87, barely above its 30‑day support of $0.84 and far below the 20‑day SMA of $1.10, indicating a steep bearish bias. The 14‑day RSI of 31 suggests the stock is oversold, while the MACD histogram remains negative, confirming downward momentum. A beta of 2.30 and 30‑day volatility of 74% signal extreme price swings, and the recent max drawdown of -94% underscores historic weakness. Fundamentally, the company posts a trailing EPS of -$2.31, negative free cash flow of $‑35.1 M, and a debt load of $63.6 M against $13.5 M of cash. Despite a gross margin of 65% and a modest operating margin, profitability remains elusive, with a profit margin of -57%. The DCF‑derived fair value of $1.99 implies an upside of over 800% relative to the current price, but the forward PE of -4.33 and negative book value per share highlight valuation distortion. The market cap of just $10 M and low average volumes point to thin liquidity, while the company’s Brazil‑centric exposure adds geographic and currency risk. Overall, the stock presents a high‑risk, high‑reward profile driven by severe valuation discount versus a fundamentally distressed business.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • RSI near oversold levels
  • Price hovering just above support
  • Bearish MACD and downward trend

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • DCF fair value suggests massive upside
  • Negative earnings and cash flow
  • High debt relative to cash

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Potential market expansion in Latin America SaaS
  • Strong gross margin indicating scalable business model
  • Current price offers a large margin of safety if turnaround succeeds

Key Metrics & Analysis

Financial Health

Revenue Growth-2.50%
Profit Margin-57.40%
P/E Ratio-4.3
ROA-4.51%
P/B Ratio-0.3
Op. Cash Flow$8.0M
Free Cash Flow$-35090376
Industry P/E36.5

Technical Analysis

TrendBearish
RSI31.4
Support$0.84
Resistance$1.26
MA 20$1.10
MA 50$1.20
MA 200$2.95
MACDBearish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Fair Value$2.00
Target Price$8.00
Upside/Downside819.65%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.30
Volatility73.85%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.